What’s New from the 2016 ESMO Clinical Guidelines

FDA Corner - Interview with Reena Philip, PHD, and Eunice Lee, PHD

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

NCI Corner - Interview with Dinah S. Singer, PHD

Small Cell Lung Cancer: The Next Challenge

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

Interview with Richard Pazdur, MD

FDA Corner - Interview with Gideon Blumenthal, MD

NCI Corner - Interview with Shakun Malik, MD

Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

COVID-19 and Lung Cancer

The Art and Science of Patient–Doctor Communication